Global Recombinant DNA (rDNA) Technology Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 02-Jul-2021
No. of pages: 116
Inquire Before Buying

Market Analysis and Insights: Global Recombinant DNA (rDNA) Technology Market

The global Recombinant DNA (rDNA) Technology market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Recombinant DNA (rDNA) Technology market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Recombinant DNA (rDNA) Technology market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Recombinant DNA (rDNA) Technology market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Recombinant DNA (rDNA) Technology market.

Global Recombinant DNA (rDNA) Technology Scope and Market Size

Recombinant DNA (rDNA) Technology market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Recombinant DNA (rDNA) Technology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Expression System

- Cloning Vector

Segment by Application

- Biotechnology and Pharmaceutical Companies

- Academic and Government Research Institutes

- Other

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- F. Hoffmann-La Roche Ltd (Genentech, Inc)

- Profacgen

- Amgen Inc

- Novartis AG

- GenScript

- Pfizer Inc

- Novo Nordisk A/S

- Eli Lilly and Company

- Sanofi

- Biocon

- GlaxoSmithKline plc

- New England Biolabs.

- Cibus

- Monsanto Company

- Horizon Discovery Group PLC

Global Recombinant DNA (rDNA) Technology Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recombinant DNA (rDNA) Technology Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Expression System
1.2.3 Cloning Vector
1.3 Market by Application
1.3.1 Global Recombinant DNA (rDNA) Technology Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Biotechnology and Pharmaceutical Companies
1.3.3 Academic and Government Research Institutes
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Recombinant DNA (rDNA) Technology Market Perspective (2016-2027)
2.2 Recombinant DNA (rDNA) Technology Growth Trends by Regions
2.2.1 Recombinant DNA (rDNA) Technology Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Recombinant DNA (rDNA) Technology Historic Market Share by Regions (2016-2021)
2.2.3 Recombinant DNA (rDNA) Technology Forecasted Market Size by Regions (2022-2027)
2.3 Recombinant DNA (rDNA) Technology Industry Dynamic
2.3.1 Recombinant DNA (rDNA) Technology Market Trends
2.3.2 Recombinant DNA (rDNA) Technology Market Drivers
2.3.3 Recombinant DNA (rDNA) Technology Market Challenges
2.3.4 Recombinant DNA (rDNA) Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Recombinant DNA (rDNA) Technology Players by Revenue
3.1.1 Global Top Recombinant DNA (rDNA) Technology Players by Revenue (2016-2021)
3.1.2 Global Recombinant DNA (rDNA) Technology Revenue Market Share by Players (2016-2021)
3.2 Global Recombinant DNA (rDNA) Technology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Recombinant DNA (rDNA) Technology Revenue
3.4 Global Recombinant DNA (rDNA) Technology Market Concentration Ratio
3.4.1 Global Recombinant DNA (rDNA) Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant DNA (rDNA) Technology Revenue in 2020
3.5 Recombinant DNA (rDNA) Technology Key Players Head office and Area Served
3.6 Key Players Recombinant DNA (rDNA) Technology Product Solution and Service
3.7 Date of Enter into Recombinant DNA (rDNA) Technology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Recombinant DNA (rDNA) Technology Breakdown Data by Type
4.1 Global Recombinant DNA (rDNA) Technology Historic Market Size by Type (2016-2021)
4.2 Global Recombinant DNA (rDNA) Technology Forecasted Market Size by Type (2022-2027)
5 Recombinant DNA (rDNA) Technology Breakdown Data by Application
5.1 Global Recombinant DNA (rDNA) Technology Historic Market Size by Application (2016-2021)
5.2 Global Recombinant DNA (rDNA) Technology Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Recombinant DNA (rDNA) Technology Market Size (2016-2027)
6.2 North America Recombinant DNA (rDNA) Technology Market Size by Type
6.2.1 North America Recombinant DNA (rDNA) Technology Market Size by Type (2016-2021)
6.2.2 North America Recombinant DNA (rDNA) Technology Market Size by Type (2022-2027)
6.2.3 North America Recombinant DNA (rDNA) Technology Market Size by Type (2016-2027)
6.3 North America Recombinant DNA (rDNA) Technology Market Size by Application
6.3.1 North America Recombinant DNA (rDNA) Technology Market Size by Application (2016-2021)
6.3.2 North America Recombinant DNA (rDNA) Technology Market Size by Application (2022-2027)
6.3.3 North America Recombinant DNA (rDNA) Technology Market Size by Application (2016-2027)
6.4 North America Recombinant DNA (rDNA) Technology Market Size by Country
6.4.1 North America Recombinant DNA (rDNA) Technology Market Size by Country (2016-2021)
6.4.2 North America Recombinant DNA (rDNA) Technology Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Recombinant DNA (rDNA) Technology Market Size (2016-2027)
7.2 Europe Recombinant DNA (rDNA) Technology Market Size by Type
7.2.1 Europe Recombinant DNA (rDNA) Technology Market Size by Type (2016-2021)
7.2.2 Europe Recombinant DNA (rDNA) Technology Market Size by Type (2022-2027)
7.2.3 Europe Recombinant DNA (rDNA) Technology Market Size by Type (2016-2027)
7.3 Europe Recombinant DNA (rDNA) Technology Market Size by Application
7.3.1 Europe Recombinant DNA (rDNA) Technology Market Size by Application (2016-2021)
7.3.2 Europe Recombinant DNA (rDNA) Technology Market Size by Application (2022-2027)
7.3.3 Europe Recombinant DNA (rDNA) Technology Market Size by Application (2016-2027)
7.4 Europe Recombinant DNA (rDNA) Technology Market Size by Country
7.4.1 Europe Recombinant DNA (rDNA) Technology Market Size by Country (2016-2021)
7.4.2 Europe Recombinant DNA (rDNA) Technology Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Recombinant DNA (rDNA) Technology Market Size (2016-2027)
8.2 Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Type
8.2.1 Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Type (2016-2027)
8.3 Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Application
8.3.1 Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Application (2016-2027)
8.4 Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Region
8.4.1 Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Recombinant DNA (rDNA) Technology Market Size (2016-2027)
9.2 Latin America Recombinant DNA (rDNA) Technology Market Size by Type
9.2.1 Latin America Recombinant DNA (rDNA) Technology Market Size by Type (2016-2021)
9.2.2 Latin America Recombinant DNA (rDNA) Technology Market Size by Type (2022-2027)
9.2.3 Latin America Recombinant DNA (rDNA) Technology Market Size by Type (2016-2027)
9.3 Latin America Recombinant DNA (rDNA) Technology Market Size by Application
9.3.1 Latin America Recombinant DNA (rDNA) Technology Market Size by Application (2016-2021)
9.3.2 Latin America Recombinant DNA (rDNA) Technology Market Size by Application (2022-2027)
9.3.3 Latin America Recombinant DNA (rDNA) Technology Market Size by Application (2016-2027)
9.4 Latin America Recombinant DNA (rDNA) Technology Market Size by Country
9.4.1 Latin America Recombinant DNA (rDNA) Technology Market Size by Country (2016-2021)
9.4.2 Latin America Recombinant DNA (rDNA) Technology Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Recombinant DNA (rDNA) Technology Market Size (2016-2027)
10.2 Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Type
10.2.1 Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Type (2016-2027)
10.3 Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Application
10.3.1 Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Application (2016-2027)
10.4 Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Country
10.4.1 Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 F. Hoffmann-La Roche Ltd (Genentech, Inc)
11.1.1 F. Hoffmann-La Roche Ltd (Genentech, Inc) Company Details
11.1.2 F. Hoffmann-La Roche Ltd (Genentech, Inc) Business Overview
11.1.3 F. Hoffmann-La Roche Ltd (Genentech, Inc) Recombinant DNA (rDNA) Technology Introduction
11.1.4 F. Hoffmann-La Roche Ltd (Genentech, Inc) Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021)
11.1.5 F. Hoffmann-La Roche Ltd (Genentech, Inc) Recent Development
11.2 Profacgen
11.2.1 Profacgen Company Details
11.2.2 Profacgen Business Overview
11.2.3 Profacgen Recombinant DNA (rDNA) Technology Introduction
11.2.4 Profacgen Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021)
11.2.5 Profacgen Recent Development
11.3 Amgen Inc
11.3.1 Amgen Inc Company Details
11.3.2 Amgen Inc Business Overview
11.3.3 Amgen Inc Recombinant DNA (rDNA) Technology Introduction
11.3.4 Amgen Inc Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021)
11.3.5 Amgen Inc Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Recombinant DNA (rDNA) Technology Introduction
11.4.4 Novartis AG Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021)
11.4.5 Novartis AG Recent Development
11.5 GenScript
11.5.1 GenScript Company Details
11.5.2 GenScript Business Overview
11.5.3 GenScript Recombinant DNA (rDNA) Technology Introduction
11.5.4 GenScript Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021)
11.5.5 GenScript Recent Development
11.6 Pfizer Inc
11.6.1 Pfizer Inc Company Details
11.6.2 Pfizer Inc Business Overview
11.6.3 Pfizer Inc Recombinant DNA (rDNA) Technology Introduction
11.6.4 Pfizer Inc Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021)
11.6.5 Pfizer Inc Recent Development
11.7 Novo Nordisk A/S
11.7.1 Novo Nordisk A/S Company Details
11.7.2 Novo Nordisk A/S Business Overview
11.7.3 Novo Nordisk A/S Recombinant DNA (rDNA) Technology Introduction
11.7.4 Novo Nordisk A/S Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021)
11.7.5 Novo Nordisk A/S Recent Development
11.8 Eli Lilly and Company
11.8.1 Eli Lilly and Company Company Details
11.8.2 Eli Lilly and Company Business Overview
11.8.3 Eli Lilly and Company Recombinant DNA (rDNA) Technology Introduction
11.8.4 Eli Lilly and Company Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021)
11.8.5 Eli Lilly and Company Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Recombinant DNA (rDNA) Technology Introduction
11.9.4 Sanofi Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021)
11.9.5 Sanofi Recent Development
11.10 Biocon
11.10.1 Biocon Company Details
11.10.2 Biocon Business Overview
11.10.3 Biocon Recombinant DNA (rDNA) Technology Introduction
11.10.4 Biocon Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021)
11.10.5 Biocon Recent Development
11.11 GlaxoSmithKline plc
11.11.1 GlaxoSmithKline plc Company Details
11.11.2 GlaxoSmithKline plc Business Overview
11.11.3 GlaxoSmithKline plc Recombinant DNA (rDNA) Technology Introduction
11.11.4 GlaxoSmithKline plc Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021)
11.11.5 GlaxoSmithKline plc Recent Development
11.12 New England Biolabs.
11.12.1 New England Biolabs. Company Details
11.12.2 New England Biolabs. Business Overview
11.12.3 New England Biolabs. Recombinant DNA (rDNA) Technology Introduction
11.12.4 New England Biolabs. Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021)
11.12.5 New England Biolabs. Recent Development
11.13 Cibus
11.13.1 Cibus Company Details
11.13.2 Cibus Business Overview
11.13.3 Cibus Recombinant DNA (rDNA) Technology Introduction
11.13.4 Cibus Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021)
11.13.5 Cibus Recent Development
11.14 Monsanto Company
11.14.1 Monsanto Company Company Details
11.14.2 Monsanto Company Business Overview
11.14.3 Monsanto Company Recombinant DNA (rDNA) Technology Introduction
11.14.4 Monsanto Company Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021)
11.14.5 Monsanto Company Recent Development
11.15 Horizon Discovery Group PLC
11.15.1 Horizon Discovery Group PLC Company Details
11.15.2 Horizon Discovery Group PLC Business Overview
11.15.3 Horizon Discovery Group PLC Recombinant DNA (rDNA) Technology Introduction
11.15.4 Horizon Discovery Group PLC Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021)
11.15.5 Horizon Discovery Group PLC Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Recombinant DNA (rDNA) Technology Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Expression System
Table 3. Key Players of Cloning Vector
Table 4. Global Recombinant DNA (rDNA) Technology Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Recombinant DNA (rDNA) Technology Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Recombinant DNA (rDNA) Technology Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Recombinant DNA (rDNA) Technology Market Share by Regions (2016-2021)
Table 8. Global Recombinant DNA (rDNA) Technology Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Recombinant DNA (rDNA) Technology Market Share by Regions (2022-2027)
Table 10. Recombinant DNA (rDNA) Technology Market Trends
Table 11. Recombinant DNA (rDNA) Technology Market Drivers
Table 12. Recombinant DNA (rDNA) Technology Market Challenges
Table 13. Recombinant DNA (rDNA) Technology Market Restraints
Table 14. Global Recombinant DNA (rDNA) Technology Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Recombinant DNA (rDNA) Technology Market Share by Players (2016-2021)
Table 16. Global Top Recombinant DNA (rDNA) Technology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant DNA (rDNA) Technology as of 2020)
Table 17. Ranking of Global Top Recombinant DNA (rDNA) Technology Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Recombinant DNA (rDNA) Technology Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Recombinant DNA (rDNA) Technology Product Solution and Service
Table 21. Date of Enter into Recombinant DNA (rDNA) Technology Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Recombinant DNA (rDNA) Technology Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Recombinant DNA (rDNA) Technology Revenue Market Share by Type (2016-2021)
Table 25. Global Recombinant DNA (rDNA) Technology Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Recombinant DNA (rDNA) Technology Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Recombinant DNA (rDNA) Technology Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Recombinant DNA (rDNA) Technology Revenue Market Share by Application (2016-2021)
Table 29. Global Recombinant DNA (rDNA) Technology Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Recombinant DNA (rDNA) Technology Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Recombinant DNA (rDNA) Technology Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Recombinant DNA (rDNA) Technology Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Recombinant DNA (rDNA) Technology Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Recombinant DNA (rDNA) Technology Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Recombinant DNA (rDNA) Technology Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Recombinant DNA (rDNA) Technology Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Recombinant DNA (rDNA) Technology Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Recombinant DNA (rDNA) Technology Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Recombinant DNA (rDNA) Technology Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Recombinant DNA (rDNA) Technology Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Recombinant DNA (rDNA) Technology Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Recombinant DNA (rDNA) Technology Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Recombinant DNA (rDNA) Technology Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Recombinant DNA (rDNA) Technology Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Recombinant DNA (rDNA) Technology Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Recombinant DNA (rDNA) Technology Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Recombinant DNA (rDNA) Technology Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Recombinant DNA (rDNA) Technology Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Recombinant DNA (rDNA) Technology Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Recombinant DNA (rDNA) Technology Market Size by Country (2022-2027) & (US$ Million)
Table 61. F. Hoffmann-La Roche Ltd (Genentech, Inc) Company Details
Table 62. F. Hoffmann-La Roche Ltd (Genentech, Inc) Business Overview
Table 63. F. Hoffmann-La Roche Ltd (Genentech, Inc) Recombinant DNA (rDNA) Technology Product
Table 64. F. Hoffmann-La Roche Ltd (Genentech, Inc) Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021) & (US$ Million)
Table 65. F. Hoffmann-La Roche Ltd (Genentech, Inc) Recent Development
Table 66. Profacgen Company Details
Table 67. Profacgen Business Overview
Table 68. Profacgen Recombinant DNA (rDNA) Technology Product
Table 69. Profacgen Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021) & (US$ Million)
Table 70. Profacgen Recent Development
Table 71. Amgen Inc Company Details
Table 72. Amgen Inc Business Overview
Table 73. Amgen Inc Recombinant DNA (rDNA) Technology Product
Table 74. Amgen Inc Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021) & (US$ Million)
Table 75. Amgen Inc Recent Development
Table 76. Novartis AG Company Details
Table 77. Novartis AG Business Overview
Table 78. Novartis AG Recombinant DNA (rDNA) Technology Product
Table 79. Novartis AG Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021) & (US$ Million)
Table 80. Novartis AG Recent Development
Table 81. GenScript Company Details
Table 82. GenScript Business Overview
Table 83. GenScript Recombinant DNA (rDNA) Technology Product
Table 84. GenScript Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021) & (US$ Million)
Table 85. GenScript Recent Development
Table 86. Pfizer Inc Company Details
Table 87. Pfizer Inc Business Overview
Table 88. Pfizer Inc Recombinant DNA (rDNA) Technology Product
Table 89. Pfizer Inc Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021) & (US$ Million)
Table 90. Pfizer Inc Recent Development
Table 91. Novo Nordisk A/S Company Details
Table 92. Novo Nordisk A/S Business Overview
Table 93. Novo Nordisk A/S Recombinant DNA (rDNA) Technology Product
Table 94. Novo Nordisk A/S Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021) & (US$ Million)
Table 95. Novo Nordisk A/S Recent Development
Table 96. Eli Lilly and Company Company Details
Table 97. Eli Lilly and Company Business Overview
Table 98. Eli Lilly and Company Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021) & (US$ Million)
Table 99. Eli Lilly and Company Recent Development
Table 100. Sanofi Company Details
Table 101. Sanofi Business Overview
Table 102. Sanofi Recombinant DNA (rDNA) Technology Product
Table 103. Sanofi Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021) & (US$ Million)
Table 104. Sanofi Recent Development
Table 105. Biocon Company Details
Table 106. Biocon Business Overview
Table 107. Biocon Recombinant DNA (rDNA) Technology Product
Table 108. Biocon Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021) & (US$ Million)
Table 109. Biocon Recent Development
Table 110. GlaxoSmithKline plc Company Details
Table 111. GlaxoSmithKline plc Business Overview
Table 112. GlaxoSmithKline plc Recombinant DNA (rDNA) Technology Product
Table 113. GlaxoSmithKline plc Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021) & (US$ Million)
Table 114. GlaxoSmithKline plc Recent Development
Table 115. New England Biolabs. Company Details
Table 116. New England Biolabs. Business Overview
Table 117. New England Biolabs. Recombinant DNA (rDNA) Technology Product
Table 118. New England Biolabs. Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021) & (US$ Million)
Table 119. New England Biolabs. Recent Development
Table 120. Cibus Company Details
Table 121. Cibus Business Overview
Table 122. Cibus Recombinant DNA (rDNA) Technology Product
Table 123. Cibus Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021) & (US$ Million)
Table 124. Cibus Recent Development
Table 125. Monsanto Company Company Details
Table 126. Monsanto Company Business Overview
Table 127. Monsanto Company Recombinant DNA (rDNA) Technology Product
Table 128. Monsanto Company Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021) & (US$ Million)
Table 129. Monsanto Company Recent Development
Table 130. Horizon Discovery Group PLC Company Details
Table 131. Horizon Discovery Group PLC Business Overview
Table 132. Horizon Discovery Group PLC Recombinant DNA (rDNA) Technology Product
Table 133. Horizon Discovery Group PLC Revenue in Recombinant DNA (rDNA) Technology Business (2016-2021) & (US$ Million)
Table 134. Horizon Discovery Group PLC Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Recombinant DNA (rDNA) Technology Market Share by Type: 2020 VS 2027
Figure 2. Expression System Features
Figure 3. Cloning Vector Features
Figure 4. Global Recombinant DNA (rDNA) Technology Market Share by Application: 2020 VS 2027
Figure 5. Biotechnology and Pharmaceutical Companies Case Studies
Figure 6. Academic and Government Research Institutes Case Studies
Figure 7. Other Case Studies
Figure 8. Recombinant DNA (rDNA) Technology Report Years Considered
Figure 9. Global Recombinant DNA (rDNA) Technology Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Recombinant DNA (rDNA) Technology Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Recombinant DNA (rDNA) Technology Market Share by Regions: 2020 VS 2027
Figure 12. Global Recombinant DNA (rDNA) Technology Market Share by Regions (2022-2027)
Figure 13. Global Recombinant DNA (rDNA) Technology Market Share by Players in 2020
Figure 14. Global Top Recombinant DNA (rDNA) Technology Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant DNA (rDNA) Technology as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Recombinant DNA (rDNA) Technology Revenue in 2020
Figure 16. Global Recombinant DNA (rDNA) Technology Revenue Market Share by Type (2016-2021)
Figure 17. Global Recombinant DNA (rDNA) Technology Revenue Market Share by Type (2022-2027)
Figure 18. North America Recombinant DNA (rDNA) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Recombinant DNA (rDNA) Technology Market Share by Type (2016-2027)
Figure 20. North America Recombinant DNA (rDNA) Technology Market Share by Application (2016-2027)
Figure 21. North America Recombinant DNA (rDNA) Technology Market Share by Country (2016-2027)
Figure 22. United States Recombinant DNA (rDNA) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Recombinant DNA (rDNA) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Recombinant DNA (rDNA) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Recombinant DNA (rDNA) Technology Market Share by Type (2016-2027)
Figure 26. Europe Recombinant DNA (rDNA) Technology Market Share by Application (2016-2027)
Figure 27. Europe Recombinant DNA (rDNA) Technology Market Share by Country (2016-2027)
Figure 28. Germany Recombinant DNA (rDNA) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Recombinant DNA (rDNA) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Recombinant DNA (rDNA) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Recombinant DNA (rDNA) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Recombinant DNA (rDNA) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Recombinant DNA (rDNA) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Recombinant DNA (rDNA) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Recombinant DNA (rDNA) Technology Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Recombinant DNA (rDNA) Technology Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Recombinant DNA (rDNA) Technology Market Share by Region (2016-2027)
Figure 38. China Recombinant DNA (rDNA) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Recombinant DNA (rDNA) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Recombinant DNA (rDNA) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Recombinant DNA (rDNA) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Recombinant DNA (rDNA) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Recombinant DNA (rDNA) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Recombinant DNA (rDNA) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Recombinant DNA (rDNA) Technology Market Share by Type (2016-2027)
Figure 46. Latin America Recombinant DNA (rDNA) Technology Market Share by Application (2016-2027)
Figure 47. Latin America Recombinant DNA (rDNA) Technology Market Share by Country (2016-2027)
Figure 48. Mexico Recombinant DNA (rDNA) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Recombinant DNA (rDNA) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Recombinant DNA (rDNA) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Recombinant DNA (rDNA) Technology Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Recombinant DNA (rDNA) Technology Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Recombinant DNA (rDNA) Technology Market Share by Country (2016-2027)
Figure 54. Turkey Recombinant DNA (rDNA) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Recombinant DNA (rDNA) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Recombinant DNA (rDNA) Technology Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. F. Hoffmann-La Roche Ltd (Genentech, Inc) Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2016-2021)
Figure 58. Profacgen Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2016-2021)
Figure 59. Amgen Inc Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2016-2021)
Figure 60. Novartis AG Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2016-2021)
Figure 61. GenScript Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2016-2021)
Figure 62. Pfizer Inc Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2016-2021)
Figure 63. Novo Nordisk A/S Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2016-2021)
Figure 64. Eli Lilly and Company Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2016-2021)
Figure 65. Sanofi Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2016-2021)
Figure 66. Biocon Revenue Growth Rate in Recombinant DNA (rDNA) Technology Business (2016-2021)
Figure 67.
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs